Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells

Blood

Volumn 90, Issue 2, 1997, Pages 651-657

  Sui, Xingwei ^b   Krantz, Sanford B ^a   Zhao, Zhizhuang ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ADULT; ARTICLE; CELL FRACTIONATION; CLINICAL ARTICLE; CROSS REACTION; ENZYME ACTIVITY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GEL FILTRATION; HUMAN; HUMAN CELL; HYPERSENSITIVITY; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0030791577     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.2.651.651_651_657     Document Type: Article

References (38)

1. Hoffman R, Boswell HS: Polycythemia vera, in Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology: Basic Principles and Practice (ed 2). New York, NY, Churchill Livingstone, 1995, p 1121
2. Green AR: Pathogenesis of polycythaemia vera. Lancet 347:844, 1996
3. Dai CH, Krantz SB, Means RT, Horn ST, Gilbert HS: Polycythemia vera blood burst-forming units erythroid are hypersensitive to interleukin-3. J Clin Invest 87:391, 1991
4. Dai CH, Krantz SB, Dessypris EN, Means RT, Horn ST, Gilbert HS: Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3, and granulocyte-macrophage colony-stimulating factor. Blood 80:891, 1992
5. Dai CH, Krantz SB, Green WF, Gilbert HS: Polycythaemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression. Br J Haematol 86:12, 1994
6. Correa PN, Eskinazi D, Axelrad AA: Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor I in vitro: Studies in an improved serum-free medium. Blood 83:99, 1994
7. Mirza AM, Correa PN, Axelrad AA: Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor receptor β subunit in circulating mononuclear cells of patients with polycythemia vera. Blood 86:877, 1995
8. Metcalf D: Hematopoietic regulators: Redundancy or subtlety. Blood 82:3515, 1993
9. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
10. Krantz SB: Erythropoietin. Blood 77:419, 1991
11. Muta K, Krantz SB, Bondurant MC, Wickrema A: Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 94:34, 1994
12. + cells. J Exp Med 183:837, 1996
13. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 76:253, 1994
14. Streuli M: Protein tyrosine phosphatases in signaling. Curr Opin Cell Biol 8:182, 1996
15. Zhao Z, Shen SH, Fischer EH: Structure, regulation, and function of SH2 domain-containing protein tyrosine phosphatases. Adv Prot Phosphatases 9:297, 1995
16. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF: Specific recruitment of SHP-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729, 1995
17. Yi T, Mui AL, Krystal G, IhIe JN: Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 13:7577, 1993
18. Cyster JG, Goodnow CC: Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocyte and determines thresholds for negative selection. Immunity 2:13, 1995
19. Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC: Association of the interferon-γ-dependent tyrosine kinase Tyk-2 with hematopoietic cell phosphatase. J Biol Chem 270:18179, 1995
20. David M, Chen HE, Goelz S, Larner AC, Neel BG: Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15:7050, 1995
21. Paulson RF, Vesely S, Siminovitch KA, Bernstein A: Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 13:309, 1996
22. Lorenz U, Bergemann AD, Steinberg HN, Flanagan JG, Li X, Galli SJ, Neel BG: Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J Exp Med 184:1111, 1996
23. Tauchi T, Feng GS, Marshall MS, Shen R, Mantel C, Pawson T, Broxmeyer HE: The ubiquitously expressed Syp phosphatase interacts with c-Kit and Grb-2 in hematopoietic cells. J Biol Chem 269:25206, 1994
24. Tauchi T, Damen JE, Toyama K, Feng GS, Broxmeyer HE, Krystal G: Tyrosine 425 within the activated erythropoietin receptor binds syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mutagenesis. Blood 87:4495, 1996
25. Dai CH, Krantz SB, Sawyer ST: Polycythemia Vera V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: A possible defect of phosphatase activity in polycythemia vera. Blood 89:3574, 1997
26. Berlin NI: Diagnosis and classification of the polycythemias. Semin Hematol 12:339, 1975
27. Zhao Z, Larocque R, Ho WT, Fischer EH, Shen SH: Purification and characterization of PTP2C, a widely distributed protein tyrosine phosphatase containing two SH2 domains. J Biol Chem 269:8780, 1994
28. Zhao Z, Shen SH, Fischer EH: Phorbol ester-induced expression, phosphorylation, and translocation of protein-tyrosine-phosphatase 1C in HL-60 cells. Proc Natl Acad Sci USA 91:5007, 1994
29. Sawada K, Krantz SB, Kans JS, Dessypris EN, Sawyer S, Glick AD, Civin CI: Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 80:357, 1987
30. Daum G, Solca F, Diltz C, Zhao Z, Cool DE, Fischer EH: A general peptide substrate for tyrosine phosphatases. Anal Biochem 211:50, 1993
31. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976
32. Zhao Z: Thiophosphate derivatives as inhibitors of tyrosine phosphatases. Biochem Biophys Res Commun 218:480, 1996
33. Zhang ZY, Malachowski WP, Van Etten RL, Dixon JE: Nature of the rate-determining steps of the reaction catalyzed by the Yersinia protein-tyrosine phosphatase. J Biol Chem 269:8140, 1994
34. Zhao Z, Zander NF, Malencik DA, Anderson SR, Fisher EH: Continuous spectrophotometric assay of protein tyrosine phosphatase using phosphotyrosine. Anal Biochem 202:361, 1992
35. Dai CH, Krantz SB: Vanadate mimics the effect of stem cell factor on highly purified human burst-forming units-erythroid in vitro but not the effect of erythropoietin. Exp Hematol 20:1055, 1992
36. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR: Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445, 1993
37. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnel JE, Yancopoulos GD: Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1348, 1995
38. Trowbridge IS, Thomas ML: CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 12:85, 1994